Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ketamine Treatment for Alcohol Use Disorder: A Systematic Review
Michael Kelson, Justin M Burnett, Amy Matthews, et al.
Cureus (2023)
Open Access | Times Cited: 19

Showing 19 citing articles:

Emerging drugs in phase II and III clinical development for the treatment of alcohol use disorder
Sophie Köhne, Thomas Hillemacher, Alexander Glahn, et al.
Expert Opinion on Emerging Drugs (2024) Vol. 29, Iss. 3, pp. 219-232
Closed Access | Times Cited: 6
Substitution therapy for patients with alcohol dependence: Mechanisms of action and efficacy
Julien Guiraud, Rainer Spanagel, Wim van den Brink
International review of neurobiology (2024), pp. 187-239
Closed Access | Times Cited: 4
Management of alcohol withdrawal syndromes in general hospital settings
Kristopher A. Kast, S. Alex Sidelnik, Shamim H. Nejad, et al.
BMJ (2025), pp. e080461-e080461
Closed Access
Xenon gas as a potential treatment for opioid use disorder, alcohol use disorder, and related disorders
Marc J. Kaufman, Edward G. Meloni
Medical Gas Research (2025)
Closed Access
Sex specific effects of ketamine, but not other glutamate receptor modulators, on ethanol self-administration and reinstatement of ethanol seeking in rats
Megan L. Bertholomey, Camryn Forbes, Bryan D. McElroy, et al.
Psychopharmacology (2025)
Closed Access
Addictions and Substance Misuse

(2025), pp. 477-560
Closed Access
Four good reasons to choose ketamine in the emergency department. A case series and literature review
Fabiana Belviso, Erika Poggiali, Eva Ioannilli, et al.
Emergency Care Journal (2024)
Open Access | Times Cited: 1
Ketamine for the Treatment of Psychiatric Disorders: A Systematic Review and Meta-Analysis
Angela T.H. Kwan, Moiz Lakhani, Gurkaran Singh, et al.
CNS Spectrums (2024), pp. 1-8
Closed Access | Times Cited: 1
Ketamine: an Emerging Agent in the Management of Neuropsychiatric Disorders
Nathan B. Menke, Elizabeth R. Hoffman, Kelsey Gaylor, et al.
Asian Journal of Psychiatry (2024) Vol. 106, pp. 104351-104351
Closed Access | Times Cited: 1
Ketamine for Adults With Substance Use Disorders
Khai Tran, Danielle MacDougall
Canadian Journal of Health Technologies (2024) Vol. 4, Iss. 2
Open Access
Acute Subjective Experiences of Intravenous Ketamine Therapy Among Medically Hospitalized Patients with Alcohol Use Disorder
Dale Terasaki
Psychedelic Medicine (2024) Vol. 2, Iss. 2, pp. 116-126
Closed Access
Cannabidiol or ketamine for preventing the impact of adolescent early drug initiation on voluntary ethanol consumption in adulthood
M. Julia García‐Fuster, Carles Colom-Rocha, Cristian Bis‐Humbert
Research Square (Research Square) (2024)
Open Access
Leserbrief zu: Ketamininfusionstherapie zur Behandlung von Depressionen – Schritt für Schritt
Udo Bonnet
PSYCH up2date (2024) Vol. 18, Iss. 03, pp. 191-192
Closed Access
Antwort zum Leserbrief: Ketamininfusionstherapie zur Behandlung von Depressionen – Schritt für Schritt
Florian Müller‐Dahlhaus, Michael Junginger, Wolfgang Kelsch
PSYCH up2date (2024) Vol. 18, Iss. 03, pp. 193-194
Closed Access
Cannabidiol or ketamine for preventing the impact of adolescent early drug initiation on voluntary ethanol consumption in adulthood
Carles Colom-Rocha, Cristian Bis‐Humbert, M. Julia García‐Fuster
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Renaissance of Ketamine
Kinga Kocur, Katarzyna Camlet, Anna Ziobro, et al.
Prospects in Pharmaceutical Sciences (2024) Vol. 22, Iss. 3, pp. 156-163
Open Access
Decreasing brain activity caused by acute administration of ketamine and alcohol – A randomized, controlled, observer-blinded experimental study
Luan Oliveira Ferreira, Esther Padilha da Silveira, Clarissa Araújo da Paz, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Therapeutic Potential of Psychedelic Compounds for Substance Use Disorders
Tamara Valdez, Valbhi Patel, Nattaphone Senesombath, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 11, pp. 1484-1484
Open Access
Reverse engineering therapeutic mechanisms of ketamine and Psychedelics: Insights from Translational Oncology for Research in Psychiatry
Elizabeth E. Klettke, Miles D. Holmes, Thomas D. Meyer, et al.
Personalized Medicine in Psychiatry (2023) Vol. 41-42, pp. 100112-100112
Closed Access | Times Cited: 1
Page 1

Scroll to top